PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 10 filers reported holding PROVENTION BIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $273,000 | +157.5% | 25,820 | +9.3% | 0.00% | – |
| Q3 2022 | $106,000 | +11.6% | 23,615 | 0.0% | 0.00% | – |
| Q2 2022 | $95,000 | -45.4% | 23,615 | -0.2% | 0.00% | – |
| Q1 2022 | $174,000 | +15.2% | 23,665 | +0.2% | 0.00% | – |
| Q3 2021 | $151,000 | -20.9% | 23,616 | +4.0% | 0.00% | -100.0% |
| Q2 2021 | $191,000 | +11.7% | 22,716 | +39.4% | 0.00% | 0.0% |
| Q1 2021 | $171,000 | +21.3% | 16,300 | -53.5% | 0.00% | 0.0% |
| Q3 2018 | $141,000 | – | 35,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |